{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:36:04Z","timestamp":1792654564504,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002767","name":"Hunan Provincial Science and Technology Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ejphar.2019.172550","type":"journal-article","created":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T11:08:53Z","timestamp":1563275333000},"page":"172550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"special_numbering":"C","title":["Glycyrrhizic acid suppresses osteoclast differentiation and postmenopausal osteoporosis by modulating the NF-\u03baB, ERK, and JNK signaling pathways"],"prefix":"10.1016","volume":"859","author":[{"given":"Ziqing","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangfei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengxiao","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2019.172550_bib1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.lfs.2017.11.005","article-title":"Glycyrrhizin ameliorates high fat diet-induced obesity in rats by activating NrF2 pathway","volume":"193","author":"Abo El-Magd","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2019.172550_bib2","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aai9338","article-title":"RON kinase: a target for treatment of cancer-induced bone destruction and osteoporosis","volume":"9","author":"Andrade","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejphar.2019.172550_bib3","first-page":"42","article-title":"RANKL in bone homeostasis","volume":"362","author":"Ash","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2019.172550_bib4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s12020-015-0721-8","article-title":"Effects of strontium ranelate on markers of cardiovascular risk in postmenopausal osteoporotic women","volume":"53","author":"Atteritano","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.ejphar.2019.172550_bib5","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1210\/jc.2013-1597","article-title":"The effect of three or six years of denosumab exposure in women with postmenopausal osteoporosis: results from the FREEDOM extension","volume":"98","author":"Bone","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2019.172550_bib6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2019.172550_bib7","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/jbmr.2032","article-title":"MiR-503 regulates osteoclastogenesis via targeting RANK","volume":"29","author":"Chen","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ejphar.2019.172550_bib8","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/jbmr.3011","article-title":"Control of bone anabolism in response to mechanical loading and PTH by distinct mechanisms downstream of the PTH receptor","volume":"32","author":"Delgado-Calle","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ejphar.2019.172550_bib9","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.bbagen.2014.01.024","article-title":"Glycyrrhizin inhibits lipopolysaccharide-induced inflammatory response by reducing TLR4 recruitment into lipid rafts in RAW264.7 cells","volume":"1840","author":"Fu","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2019.172550_bib10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/leu.2017.168","article-title":"Aberrant splicing of the tumor suppressor CYLD promotes the development of chronic lymphocytic leukemia via sustained NF-\u03baB signaling","volume":"32","author":"Hahn","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.ejphar.2019.172550_bib11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1210\/en.2015-1726","article-title":"Binding selectivity of abaloparatide for PTH-type-1-receptor conformations and effects on downstream signaling","volume":"157","author":"Hattersley","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2019.172550_bib12","doi-asserted-by":"crossref","first-page":"81ra35","DOI":"10.1126\/scitranslmed.3002212","article-title":"A phosphorus-based dendrimer targets inflammation and osteoclastogenesis in experimental arthritis","volume":"3","author":"Hayder","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejphar.2019.172550_bib13","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.bbrc.2014.05.034","article-title":"Schisantherin A suppresses osteoclast formation and wear particle-induced osteolysis via modulating RANKL signaling pathways","volume":"449","author":"He","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2019.172550_bib14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/0022034518797275","article-title":"Berberine ameliorates periodontal bone loss by regulating gut microbiota","volume":"98","author":"Jia","year":"2019","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.ejphar.2019.172550_bib15","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.pharep.2016.05.013","article-title":"Glabridin and glycyrrhizic acid show no beneficial effect on the chemical composition and mechanical properties of bones in ovariectomized rats, when administered in moderate dose","volume":"68","author":"Kaczmarczyk-Sedlak","year":"2016","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejphar.2019.172550_bib16","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1080\/15548627.2016.1239678","article-title":"A novel PINK1- and PARK2-dependent protective neuroimmune pathway in lethal sepsis","volume":"12","author":"Kang","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.ejphar.2019.172550_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"30","author":"Kanis","year":"2019","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.ejphar.2019.172550_bib18","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2016.02.043","article-title":"Bone and muscle endocrine functions: unexpected paradigms of inter-organ communication","volume":"164","author":"Karsenty","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2019.172550_bib19","first-page":"462","article-title":"Description of a new method of ovariectomy in female rats","volume":"52","author":"Khajuria","year":"2012","journal-title":"Rev. Bras. Reumatol."},{"key":"10.1016\/j.ejphar.2019.172550_bib20","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1007\/s00776-013-0433-y","article-title":"Osteoprotective effect of propranolol in ovariectomized rats: a comparison with zoledronic acid and alfacalcidol","volume":"18","author":"Khajuria","year":"2013","journal-title":"J. Orthop. Sci."},{"key":"10.1016\/j.ejphar.2019.172550_bib21","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1210\/jc.2012-1027","article-title":"Benefits and risks of bisphosphonate therapy for osteoporosis","volume":"97","author":"Khosla","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2019.172550_bib22","doi-asserted-by":"crossref","first-page":"E601","DOI":"10.3390\/ijms19020601","article-title":"Inhibitory effect of purpurogallin on osteoclast differentiation in vitro through the downregulation of c-fos and NFATc1","volume":"19","author":"Kim","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2019.172550_bib23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.nbd.2011.12.056","article-title":"Glycyrrhizic acid affords robust neuroprotection in the postischemic brain via anti-inflammatory effect by inhibiting HMGB1 phosphorylation and secretion","volume":"46","author":"Kim","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2019.172550_bib24","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1089\/thy.2016.0432","article-title":"Glycyrrhizin, a direct HMGB1 antagonist, ameliorates inflammatory infiltration in a model of autoimmune thyroiditis via inhibition of TLR2-HMGB1 signaling","volume":"27","author":"Li","year":"2017","journal-title":"Thyroid"},{"key":"10.1016\/j.ejphar.2019.172550_bib25","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3389\/fphar.2017.00627","article-title":"The beneficial effect of praeruptorin C on osteoporotic bone in ovariectomized mice via suppression of osteoclast formation and bone resorption","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172550_bib26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa022436","article-title":"The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis","volume":"350","author":"Meunier","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2019.172550_bib27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bone.2010.12.024","article-title":"The kidney and bisphosphonates","volume":"49","author":"Miller","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.ejphar.2019.172550_bib28","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jama.2016.11136","article-title":"Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial","volume":"316","author":"Miller","year":"2016","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ejphar.2019.172550_bib29","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1159\/000371845","article-title":"The RANKL-RANK story","volume":"61","author":"Nagy","year":"2015","journal-title":"Gerontology"},{"key":"10.1016\/j.ejphar.2019.172550_bib30","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.18632\/oncotarget.22930","article-title":"Hypericin targets osteoclast and prevents breast cancer-induced bone metastasis via NFATc1 signaling pathway","volume":"9","author":"Ouyang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2019.172550_bib31","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.bcp.2014.06.009","article-title":"Hypericin suppresses osteoclast formation and wear particle-induced osteolysis via modulating ERK signalling pathway","volume":"90","author":"Ouyang","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172550_bib32","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bone.2013.02.012","article-title":"The beneficial effect of icaritin on osteoporotic bone is dependent on the treatment initiation timing in adult ovariectomized rats","volume":"55","author":"Peng","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.ejphar.2019.172550_bib33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1081\/DMR-100104400","article-title":"The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling","volume":"33","author":"Ploeger","year":"2001","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.ejphar.2019.172550_bib34","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0140-6736(10)62349-5","article-title":"Osteoporosis: now and the future","volume":"377","author":"Rachner","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2019.172550_bib35","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s00774-012-0413-x","article-title":"Glycyrrhizic acid (GCA) as 11\u03b2-hydroxysteroid dehydrogenase inhibitor exerts protective effect against glucocorticoid-induced osteoporosis","volume":"31","author":"Ramli","year":"2013","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.ejphar.2019.172550_bib36","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.beem.2018.09.005","article-title":"Postmenopausal osteoporosis: assessment and management","volume":"32","author":"Rizzoli","year":"2018","journal-title":"Best Pract. Res. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.ejphar.2019.172550_bib37","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2019.172550_bib38","doi-asserted-by":"crossref","first-page":"510","DOI":"10.47102\/annals-acadmedsg.V40N11p510","article-title":"Stevens\u2013Johnson syndrome due to strontium ranelate","volume":"40","author":"Tan","year":"2011","journal-title":"Ann. Acad. Med. Singapore"},{"key":"10.1016\/j.ejphar.2019.172550_bib39","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.phrs.2018.09.022","article-title":"Dioscin:A diverse acting natural compound with therapeutic potential in metabolic diseases","volume":"137","author":"Tao","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2019.172550_bib40","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1126\/science.289.5484.1504","article-title":"Bone resorption by osteoclasts","volume":"289","author":"Teitelbaum","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2019.172550_bib41","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrg1122","article-title":"Genetic regulation of osteoclast development and function","volume":"4","author":"Teitelbaum","year":"2003","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ejphar.2019.172550_bib42","first-page":"802473","article-title":"Teriparatide induced delayed persistent hypercalcemia","volume":"2014","author":"Thiruchelvam","year":"2014","journal-title":"Case. Rep. Endocrinol."},{"key":"10.1016\/j.ejphar.2019.172550_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047616","article-title":"Bisphosphonates and risk of upper gastrointestinal cancerea case control study using the general practice research database (GPRD)","volume":"7","author":"Wright","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2019.172550_bib44","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.immuni.2011.01.014","article-title":"Nuclear export of the NF-\u03baB inhibitor I\u03baB\u03b1 is required for proper B cell and secondary lymphoid tissue formation","volume":"34","author":"Wuerzberger-Davis","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.ejphar.2019.172550_bib45","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1248\/bpb.18.337","article-title":"Administration-route dependency of absorption of glycyrrhizin in rats: intraperitoneal administration dramatically enhanced bioavailability","volume":"18","author":"Yamamura","year":"1995","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejphar.2019.172550_bib46","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1007\/s10620-011-1789-5","article-title":"Efficacy of intravenous glycyrrhizin in the early stage of acute onset autoimmune hepatitis","volume":"56","author":"Yasui","year":"2011","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.ejphar.2019.172550_bib47","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1159\/000485045","article-title":"High mobility group Box1 inhibitor glycyrrhizic acid attenuates kidney injury in streptozotocin-induced diabetic rats","volume":"42","author":"Zhang","year":"2017","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.ejphar.2019.172550_bib48","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3389\/fphar.2018.01028","article-title":"Hesperetin prevents bone resorption by inhibiting RANKL-induced osteoclastogenesis and JnkMediated irf-3\/c-jun activation","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172550_bib49","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejphar.2016.04.006","article-title":"Glycyrrhizic acid pretreatment prevents sepsis-induced acute kidney injury via suppressing inflammation, apoptosis and oxidative stress","volume":"781","author":"Zhao","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172550_bib50","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.bbrc.2017.01.179","article-title":"Gastrodin inhibits osteoclastogenesis via down-regulating the NFATc1 signaling pathway and stimulates osseointegration in vitro","volume":"484","author":"Zhou","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919305023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919305023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:32:01Z","timestamp":1757975521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299919305023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":50,"alternative-id":["S0014299919305023"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172550","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycyrrhizic acid suppresses osteoclast differentiation and postmenopausal osteoporosis by modulating the NF-\u03baB, ERK, and JNK signaling pathways","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172550","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"172550"}}